A Pilot Study of Monotherapy with a Non-Vitamin K-Antagonist Oral Anticoagulant following Watchman Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation
| Autor: | David Lerner, David Rubenson, Michael R. Smith, Jessica Funk, Monique Edwards-Mobley, Steven Romero, Gwen Janzcyk, Matthew J. Price, Douglas N. Gibson, Carmen Wheeler, Ashish Rastogi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Appendage
medicine.medical_specialty business.industry medicine.drug_class Non valvular atrial fibrillation Atrial fibrillation Vitamin K antagonist medicine.disease chemistry.chemical_compound Regimen chemistry Edoxaban Left atrial Internal medicine cardiovascular system medicine Cardiology cardiovascular diseases Thrombus Cardiology and Cardiovascular Medicine business |
| Zdroj: | Structural Heart. 4:288-292 |
| ISSN: | 2474-8706 |
| Popis: | The optimal medical therapy early after left atrial appendage closure (LAAC) is not well defined. A regimen that prevents thromboembolic events and device-related thrombus (DRT) while minimizing bl... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|